OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

Conditions:   Inflammation Corneal;   Pain, Postoperative Intervention:   Drug: OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL Sponsor:   Oculis Recruiting

Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials